ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
72 hedge funds and large institutions have $10.8M invested in Anthera Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
–
Holders Change %
0%
% of All Funds
1.8%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
25
Reduced
19
Closed
11
Calls
$91K
Puts
$164K
Net Calls
-$73K
Net Calls Change
-$309K
Top Buyers
| 1 |
A
Abingworth
London,
United Kingdom
|
+$476K |
| 2 |
Millennium Management
New York
|
+$235K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$162K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$160K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$145K |
Top Sellers
| 1 |
PAI
ProQuest Associates IV
Naples,
Florida
|
-$5.99M |
| 2 |
PA
Perceptive Advisors
New York
|
-$4.6M |
| 3 |
BC
Broadfin Capital
New York
|
-$3.64M |
| 4 |
SCM
Sio Capital Management
New York
|
-$2.84M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.02M |
